C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/56 (2006.01) A61K 38/48 (2006.01) C12N 9/00 (2006.01) C12N 9/50 (2006.01) C12N 9/64 (2006.01)
Patent
CA 2529589
The present invention provides method for the treatment of a disease by applying a medicament comprising a protease with a defined specificity is capable to hydrolyze specific peptide bonds within a target substrate related to such disease. The proteases with such a defined specificity can further be used for related therapeutic or diagnostic purposes.
La présent invention concerne un procédé de traitement d'une maladie par application d'un médicament contenant une protéase ayant une spécificité définie. Ce procédé permet l'hydrolyse de liaisons peptidiques spécifiques dans un substrat cible lié à une telle maladie. Les protéases ayant une telle spécificité peuvent également être utilisées à des fins thérapeutiques ou diagnostiques connexes.
Haupts Ulrich
Kettling Ulrich
Koltermann Andre
Scheidig Andreas
Voetsmeier Christian
Bayer Schering Pharma Aktiengesellschaft
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Direvo Biotech Ag
LandOfFree
New biological entities and the pharmaceutical or diagnostic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New biological entities and the pharmaceutical or diagnostic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New biological entities and the pharmaceutical or diagnostic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2030198